Furthermore, through risk score analysis based on bulk-seq, we observed that the elevated expression of FBXL5, PSMB2, and PSMD12 was inversely correlated with poor prognosis, suggesting their protective role in CRC. This evidence concerns the gene PSMB2 and colorectal carcinoma.